CRON Stock Summary and Trading Ideas (Cronos Group - Common Share | NASDAQ:CRON)

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Cronos Group - Common Share trades on the NASDAQ stock market under the symbol CRON.

As of October 22, 2026, CRON stock price climbed to $3.44 with 965,316 million shares trading.

CRON has a beta of 0.32, meaning it tends to be less sensitive to market movements. CRON has a correlation of 0.01 to the broad based SPY ETF.

CRON has a market cap of $1.27 billion. This is considered a Small Cap stock.

Last quarter Cronos Group - Common Share reported $53 million in Revenue and $.09 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.08.

In the last 3 years, CRON traded as high as $3.61 and as low as $1.60.

The top ETF exchange traded funds that CRON belongs to (by Net Assets): MJ, DFIS, DFIC, ONEQ, DFAX.

CRON has outperformed the market in the last year with a price return of +37.8% while the SPY ETF gained +14.9%. CRON has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +23.0% and +6.3%, respectively, while the SPY returned +2.3% and -1.7%, respectively.

CRON support price is $3.32 and resistance is $3.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRON shares will trade within this expected range on the day.